A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The primary hypothesis of this study is that concomitant multiple-dose administration of PN
400 does not interfere with the platelet inhibitory effects of enteric-coated low-dose
aspirin (81 mg), as measured by serum thromboxane B2 inhibition.